Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. Apr 27, 2022; 14(4): 329-340
Published online Apr 27, 2022. doi: 10.4240/wjgs.v14.i4.329
Table 1 Baseline characteristics of the study subjects
Patients56
Median age, yr (range)57 (26-77)
Male, n (%)30 (53.6)
Number of lesions, n (%)
154 (96.4)
22 (3.6)
Medications, n (%)
Aspirin3 (5.3)
Clopidogrel1 (1.8)
Dual antiplatelets2 (3.6)
Anticoagulants0
NSAIDs0
Patients that underwent colonoscopy39 (69.6)
Colonoscopy positive for adenoma18 (46.2)
Lesions58
Location, n (%)
Bulb9 (15.5)
Second portion47 (81.0)
Third portion2 (3.4)
Macroscopic type, n (%)
Ip10 (17.2)
Is24 (41.4)
IIa or IIb24 (41.4)
Biopsy diagnosis, n (%)
Adenoma/LGD55 (94.8)
Adenoma/HGD2 (3.4)
Adenocarcinoma1 (1.7)